AACR 2026 Cancer Disparities Report Highlights Patient Stories, Social Determinants and Community Navigation
The AACR Cancer Disparities Progress Report 2026 presents patient narratives across colorectal, Hodgkin, breast, AL amyloidosis, myoepithelial carcinoma (MEC) and hepatitis B-related liver cancers, describing delayed diagnosis, treatment and referrals. Disparities stem from both biological factors and social determinants such as access to care and healthy food; some Indigenous communities travel 680-mile round trips to Mayo every two weeks. Asian communities show high hepatitis B positivity and liver cancer mortality but underuse screening due to cultural reluctance to discuss health. Community navigators proved effective, and sexual and gender minorities call for more affirming providers; speakers urge continued cancer research funding as a national priority.
Narratives: multiple patients with colorectal/Hodgkin/breast/AL amyloidosis/myoepithelial carcinoma (MEC)/hepatitis B-related liver cancer describe experiences of diagnosis, treatment, and referral delays, highlighting accessibility gaps across different populations.; Social determinants: disparities stem from both biological factors and social determinants such as healthcare access and access to healthy food; some Indigenous tribes have difficulty accessing specialty care due to transportation barriers (e.g., a 680-mile round trip to Mayo every two weeks).; Hepatitis B in Asian communities: Asian communities have high HBV positivity rates and high liver cancer mortality, but a culture of "not wanting to talk about health issues" and lack of awareness lead to underuse of screening.; Responses: "community navigators" have proven effective—spreading information in the community, encouraging screening, and helping connect to follow-up; sexual/gender minority groups call for more "affirming" care providers.; Advocacy: multiple storytellers urge "don't stop cancer research funding" and call for making cancer disparities research a national priority (an MEC patient's family even founded a nonprofit to advance research and a cure).; Positioning: advocacy/public health report, not basic science research.
- Narratives: multiple patients with colorectal/Hodgkin/breast/AL amyloidosis/myoepithelial carcinoma (MEC)/hepatitis B-related liver cancer describe experiences of diagnosis, treatment, and referral delays, highlighting accessibility gaps across different populations.
- Social determinants: disparities stem from both biological factors and social determinants such as healthcare access and access to healthy food; some Indigenous tribes have difficulty accessing specialty care due to transportation barriers (e.g., a 680-mile round trip to Mayo every two weeks).
- Hepatitis B in Asian communities: Asian communities have high HBV positivity rates and high liver cancer mortality, but a culture of "not wanting to talk about health issues" and lack of awareness lead to underuse of screening.
- Responses: "community navigators" have proven effective—spreading information in the community, encouraging screening, and helping connect to follow-up; sexual/gender minority groups call for more "affirming" care providers.
- Advocacy: multiple storytellers urge "don't stop cancer research funding" and call for making cancer disparities research a national priority (an MEC patient's family even founded a nonprofit to advance research and a cure).
- Positioning: advocacy/public health report, not basic science research.
Source: YouTube